Regenyx Medical
PrivateLast Round
Accelerator
Jun 5, 2025
Total Funding Raised
$2.4M
Company Overview
Regenyx Medical operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in July 2023.
Regenyx Medical is a biotechnology company that develops peptide-based hydrogel biomaterials for soft tissue restoration and bone healing applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenyx Medical Comparables
Compare Regenyx Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| inSoma Bio | 83% | |
| Conexeu Sciences Inc. | 77% | |
| BellaSeno | 75% |
For institutional investors. Book with your work email.
Regenyx Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 5, 2025 | ||||
| Grant | Jul 1, 2023 | ||||
| Grant | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Regenyx Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Israel Innovation Authority | Grant |
| American Society of Plastic Surgeons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
Received funding from MedTech Innovator and ASPS.
- Jul 2, 2024
Grew 150% QoQ, from 2 to 5 employees.
For institutional investors. Book with your work email.
Regenyx Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenyx Medical's valuation, stock price, and market status.
Is Regenyx Medical a public or private company?
Regenyx Medical is a private company.
What is the current stock price of Regenyx Medical?
Regenyx Medical is a private company, so its shares have no public market price. Caplight tracks Regenyx Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenyx Medical worth (valuation)?
Valuation information for Regenyx Medical is not publicly available.
Can I buy Regenyx Medical stock?
Regenyx Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenyx Medical's last funding round?
Regenyx Medical's most recent funding round was Accelerator on June 5, 2025.
Who are the main investors in Regenyx Medical?
Key investors in Regenyx Medical include Israel Innovation Authority.
Will Regenyx Medical IPO soon?
No public IPO plans have been announced for Regenyx Medical.
How can I track Regenyx Medical secondary market activity?
Caplight tracks bids, offers, and trades in Regenyx Medical's shares on secondary markets.